You are here

Samsung's drug-making unit soars on market debut

Friday, November 11, 2016 - 05:50


SHARES in Samsung's drug-making unit soared almost six per cent on their market debut on Thursday, after one of South Korea's biggest ever initial public offerings that raised nearly US$2 billion.

Samsung Biologics, a contract manufacturer of biotech drugs for global

Market voices on:

Pair your daily business read with the perfect cup of espresso.

Subscribe to The Business Times today to receive your very own Nespresso Inissia coffee machine worth $188.

Find out more at

Powered by GET.comGetCom